Frontlight ResearchEarly access
Down syndrome trials in Ireland
1 of 3 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 2Not yet taking people in IrelandA Study to Evaluate Mivelsiran in Adult Participants With Early-Stage Down Syndrome-Associated Alzheimer's Disease (DS-AD)
- Where
- Dublin 24
- Age
- 40 years to 55 years
- People
- 58 worldwide
- Run by
- Alnylam Pharmaceuticals
See details and how to joinNCT07636811 · EU 2025-523390-42-00